CAAS Capital Management’s Envoy Medical COCH Stock Holding History

CAAS Capital Management’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-113,869	Closed	-$1.17M	–	670
2023 Q2	$1.17M	Hold	113,869	–	–	0.08%	235
2023 Q1	$1.14M	Buy	113,869 +42,669	+60%	+$428K	0.06%	268
2022 Q4	$713K	Hold	71,200	–	–	0.04%	334
2022 Q3	$699K	Hold	71,200	–	–	0.03%	445
2022 Q2	$698K	Hold	71,200	–	–	0.03%	460
2022 Q1	$696K	Buy	71,200 +800	+1%	+$7.79K	0.03%	353
2021 Q4	$686K	Buy	+70,400	New	+$687K	0.02%	494

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

CAAS Capital Management's COCH Position: Q3 2023 in Review

CAAS Capital Management sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 113,869 shares — an estimated $1.17M sold.

CAAS Capital Management first reported a position in COCH in Q4 2021 and held it in 7 quarters. The position peaked at $1.17M in Q2 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

CAAS Capital Management reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
CAAS Capital Management sold 113,869 Envoy Medical shares in Q3 2023, an estimated $1.17M.
CAAS Capital Management first reported a position in Envoy Medical in Q4 2021 and held it in 7 quarters.
CAAS Capital Management's Envoy Medical position peaked at $1.17M in Q2 2023.
16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on CAAS Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.